Get a data-driven view on India’s markets for 2025.We discuss valuations, earnings trajectory, key macro themes, and where opportunities (and risks) lie across sectors and IPOs.Perfect for investors and analysts looking to position portfolios for the next growth cycle.
In this debut episode of Fident Fineprint, we explore how India is positioned to benefit from long-term growth in: Biotech innovation CDMO opportunities GLP-1 therapies (obesity & diabetes). Get insights into global pharma shifts and how Fident is investing across these high-potential themes.
In this edition we dive deep into the rise of flex workspaces & why they stand out on growth and profitability amongst other commercial real estate plays like hotels, malls, REITs and cinemas
Our Annual Outlook Webinar 2026 – Year of Revival saw an engaging discussion on what changed in 2025, what lies ahead for markets in 2026, and how investors should stay focused on long-term outcomes.
“The biggest risk of all, is not taking one.”- Mellody Hobson
Copyright 2024 Fident Asset Management. All rights reserved.
Copyright 2024 Fident Asset Management. All rights reserved.